Gyawali B, Ramakrishna K, Dhamoon AS. Sepsis The evolution in definition, pathophysiology, and management. SAGE open medicine. 2019; 7: 1983-5043.
World Health Organization. WHO Report on the burden of endemic health careassociated infection worldwide. 2020; 1: 11-21.
Li LL, Dai B, Sun YH, Zhang TT. The activation of IL-17 signaling pathway promotes pyroptosis in pneumonia-induced sepsis. Annals of Translational Medicine. 2020; 1: 8-11.
Gregoriano C, Heilmann E, Molitor A, Schuetz P. Role of prokalsitonin use in the management of sepsis. Journal of thoracic disease. 2020; 1: 1-12.
Tan XP, Jia SW. The Value of Preoperative Neutrophil to Lymphocyte Count Ratio (NLR) in Assessing the Prognosis of Postoperative Patients with Non-B non-C Hepatocellular Carcinoma. 2022; 10: 151-337
Hermawan A. The Environmental Factors and Sociodemographic Characteristics of Pneumonia Incidence in Indonesia. Jurnal Ilmu Kesehatan. 2022; 4: 1155-1164.
Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, Whitney CG. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. American journal of respiratory and critical care medicine. 2019; 7: 45-67.
Surviving Sepsis Campaign : International Guidelines for Management of Severe Sepsis and Septic Shock. 2021; 1: 1-15.
Singer M, Deutchman C, Seymour WC, Djillali AD, Bellomo R. The Third International Consensus Defini-tions for sepsis and septic shock. 2016; 8: 6-804.
Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. regional, and national sepsis incidence and mortality, analysis for the Global Burden of Disease Study. Lancet (London, England). 2020; 395: 11-200.
Jingyuan L, Liu A, Liuluan V, Zhu W, Yue A, Zhang S, Ang L. The effect of age on the clinical characteristics and innate immune cell function in the patients with abdominal sepsis. Frontiers in Physiology. 2022; 1: 434-952.
Stevens J, Georges A, Samaha SY, Giin B, Chong BP, Casserly MM, et al. Risk and prognostic factors in very old patients with sepsis secondary to community-acquired pneumonia. Journal of Clinical Medicine. 2019; 2: 287-961.
Cillóniz Z, Catia A. Risk and prognostic factors in very old patients with sepsis secondary to community-acquired pneumonia. Journal of Clinical Medicine. 2019; 7: 9-61.
Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med. 2016; 3: 259-272.
Lyu X, Xu Q, Cai G, Yan J, Yan M. Efficacies of fluid resuscitation as guided by lactate clearance rate and central venous oxygen saturation in patients with septic shock. Zhonghua yi xue za zhi. 2015; 7: 496-500.
Timothy D, Girard A, Steven M, Opal E, Wesley P, Ely E. Insights into Severe Sepsis in Older Patients: From Epidemiology to Evidence-Based Management. Clinical Infectious Diseases. 2005; 1: 427-876.
Khaled A, Ali U, Esmaeil S, Ali G, Shalaby S, Afaf J, et al. Neutrophil To Lymphocyte Ratio (NLR) as A Promising Prognostic Marker in Critically Septic Patients. The Egyptian Journal of Hospital Medicine. 2022; 1: 19-52.
Dimitrios N, Pantzaris V, Christina K, Platanaki D, Charalampos V, Pierrako N,et al. Neutrophil to lymphocyte Ratio Relation to Sepsis Severity Scores and Inflammatory Biomarkers in Patients with Community-acquired Pneumonia. 2018; 1: 1-9.
Oda S, Matsumoto H, Togami Y, Yoshimura J, Ito H, Onishi S, Oda J. Integrated analysis of messenger RNA and microRNA in patients with community- acquired pneumonia-associated sepsis. 2023; 21: 275-5626.
Koval DA, Kseniia A, Bielos S. Neutrophil to lymphocyte ratio (NLR) as a marker of COVID-19-associated pneumonia progression. 2022; 10: 1399-3003.
Hemant A, Jain X, Dileep S, Goyal H, Shubham E, Jain A. Diagnostic accuracy of prokalsitonin as a marker of neonatal sepsis. International Journal of Contemporary Pediatrics. 2023; 10: 2349-3291.
Jonathan J, Erwin F, Pradian A, Ardi V, Zulfariansyah L. Correlation Between Neutrophil lymphocyte Count Ratio and Prokalsitonin in Sepsis and Septic Shock. Majalah Kedokteran Bandung. 2019; 10: 15-395.
Daoub M, Mustafa A. The Neutrophil Lymphocyte Ratio (NLR); recycled as Predictor of Angiographic Coronary Artery Disease Severity in stable Ischaemic Heart Disease. Clinical cardiology and cardiovascular interventions. 2022; 10: 419-2641.
Oana A, Tatiana H, Miron V, Afrasinei G, Lucian U, Miron FD. The prognostic value of the neutrophil-to-lymphocyte ratio in patients with advanced non-small-cell lung cancer and pulmonary comorbidities. 2020; 1: 1-19.
Antic D, Jelicic J, Trajkovic G, Balint MT, Bila J, Markovic O, Mihaljevic B. Is it possible to improve prognostic value of NCCN-IPI in patients with diffuse large B cell lymphoma The prognostic significance of comorbidities. Annals of Hematology.2018; 10: 17-3170.
Prozan L, Shusterman E, Ablin J, Mitelpunkt A, Meilik WA, Adler A, Kehat O. Prognostic value of neutrophil to lymphocyte ratio in COVID-19 compared with Influenza and respiratory syncytial virus infection. 2021; 10: 21-927.
Koza Y. What is the clinical benefit of neutrophil lymphocyte ratio in cardiovascular patients?. Journal of cardiovascular and thoracic research. 2014; 1: 1-28.
Lili L, Zhan O, Yang A, Liu S, Yanxiang D, Cheng W, et al. Predictive Value of Neutrophil/Lymphocyte Ratio (NLR) on Cardiovascular Events in Patients with COVID-19. International Journal of General Medicine. 2021; 1: 80-173.
Parthasarathi A, Basavaraja CK, Arunachala S, Chandran S, Venkata H, Satheesh A, et al. Comorbidities influence the predictive power of hematological markers for mortality in hospitalized COVID-19 patients. Advances in respiratory medicine. 2022; 1: 1-17.
Shankar SM, Saha R, Wilson J. Rate and risk factors for rehospitalisation in sepsis survivors: systematic review and meta-analysis. 2020; 1: 19-134.
Cleland DA, Eranki AP. In StatPearls Treasure Island FL StatPearls. 2024; 1: 539-794.
Çil G, Karadeniz S, Yenigün G. Evaluation of the relationships between prokalsitonin and neutrophil lymphocyte ratio and platelet lymphocyte ratio in patients with pneumonia. European Review for Medical and Pharmacological Sciences. 2022; 26: 3200-3205.
Kyriazopoulou E, Antoniou LL, Adamis G, Panagaki A, Melachroino N, Drakou E, et al. Prokalsitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial. American Journal of Respiratory and Critical Care Medicine. 2010; 1: 1-20.